Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
The Ministry conducted a Third-Party Physical Evaluation of the MPLADS works completed during the period 01-04-2014 to 31-03-2019, in 216 districts across the country. The Evaluation was done in the year 2021 and the agency submitted final report on 31-8-2021.
Suggestions for increasing annual MPLAD funds were received from Members of Parliament including members from Tamil Nadu.
The Cabinet approval for the scheme has been granted till 2025-26. Any increase in the firmed-up cost of the scheme beyond 20% is to be brought before the Cabinet after approval of the competent authority. Ministry will examine the proposal prior to completion of extension period of the scheme i.e. FY 2025-26 following due process of third-partyaudit, consultation with stakeholders and keeping in view the requests received from Hon’ble MPs over time.
This information was given by the Minister of State (Independent Charge), Ministry of Statistics and Programme Implementation (MoSPI), Shri Rao Inderjit Singh in a written reply in the Lok Sabha today.
Increase in MPLAD funds subject to Cabinet approval when proposed rise exceeds approved threshold, with pre extension review. Third party evaluation of MPLADS works (01 04 2014 to 31 03 2019) was completed with a final report submitted on 31 08 2021; suggestions to increase annual MPLADS funding were received from MPs. The scheme is approved through FY 2025 26; proposed increases beyond the established funding threshold require Cabinet approval after competent authority clearance, and the Ministry will examine proposals before extension, following third party audit and stakeholder consultation.Press 'Enter' after typing page number.